Multiple endocrine neoplasia type 2B - Genetic basis and clinical expression

Surgical Oncology

Volumn 9, Issue 3, 2000, Pages 111-118

  Lee, N C ^a   Norton, J A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Medullary thyroid carcinoma; Mucosal neuroma syndrome; Multiple endocrine neoplasia type 2B; Pheochromocytoma; RET proto oncogene

Indexed keywords

ADRENALECTOMY; AMINO ACID SUBSTITUTION; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CANCER GENETICS; CANCER RISK; CANCER SURGERY; GANGLIONEUROMA; GENE MUTATION; GENETIC SCREENING; HUMAN; LYMPH NODE METASTASIS; NEUROFIBROMATOSIS; NEUROMA; ONCOGENE RET; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTO ONCOGENE; SKELETON MALFORMATION; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

ADRENAL GLAND NEOPLASMS; AGE OF ONSET; CARCINOMA, MEDULLARY; DROSOPHILA PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, DOMINANT; GENETIC SCREENING; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; MUTATION; NEUROMA; PHENOTYPE; PHEOCHROMOCYTOMA; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; RISK FACTORS; THYROID NEOPLASMS;

EID: 0034445955     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-7404(00)00038-4     Document Type: Article

References (59)

1. Erdheim J. Zur normalen und pathologischen histologie der glandula thyroidea, parathyroidea, und hypophysis. Beitraege zur Pathologischen Anatomie und Allgemeinen Pathologie. 33:1903;158.
2. Wermer P. Genetic aspects of adenomatosis of endocrine glands. American Journal of Medicine. 16:1954;363-371.
3. Hazard J.B., Hawk W.A., Crile G. Medullary (solid) carcinoma of the thyroid - a clinicopathologic entity. Journal of Clinical Endocrinology and Metabolism. 19:1959;152-161.
4. Sipple J.H. The association of pheochromocytoma with carcinoma of the thyroid gland. American Journal of Medicine. 31:1961;163-166.
5. Steiner A.L., Goodman A.D., Powers S.R. Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism, and Cushing's disease. multiple endocrine neoplasia, type 2 Medicine. 17:1968;371-409.
6. Williams E.D., Pollock D.J. Multiple mucosal neuromata with endocrine tumours. a syndrome allied to Von Recklinghausen's disease Journal of Pathology and Bacteriology. 91:1966;71-80.
7. Gorlin R.J., Sedano H.O., Vickers R.A., Cervenka J. Multiple mucosal neuromas, pheochromocytoma and medullary carcinoma of the thyroid - a syndrome. Cancer. 22:1968;293-299.
8. Schimke R.N., Hartmann W.H., Prout T.E., Rimoin D.L. Syndrome of bilateral pheochromocytoma, medullary thyroid carcinoma and multiple neuromas. New England Journal of Medicine. 279(1):1968;1-7.
9. Chong G.C., Beahrs O.H., Sizemore G.W., Woolner L.H. Medullary carcinoma of the thyroid gland. Cancer. 35:1975;695-704.
10. Ponder B.A., Smith D. The MEN II syndromes and the role of the ret proto-oncogene. Advances in Cancer Research. 70:1996;180-222.
11. Farndon J.R., Leight G.S., Dilley W.B., Baylin S.B., Smallridge R.C., Harrison T.S., Wells S.A. Familial medullary thyroid carcinoma without associated endocrinopathies. a distinct clinical entity British Journal of Surgery. 73:1986;278-281.
12. Eng C. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschprung's disease. New England Journal of Medicine. 335(13):1996;943-951.
13. Norton J.A., Froome L.C., Farrell R.E., Wells S.A. Multiple endocrine neoplasia type IIb - the most aggressive form of medullary thyroid carcinoma. Surgical Clinics of North America. 59(1):1979;109-118.
14. Le H.N., Norton J.A. Perspective on RET proto-oncogene and thyroid cancer. The Cancer Journal. 6(2):2000;50-57.
15. Raue F., Frank-Raue K., Grauer A. Multiple endocrine neoplasia type 2 - clinical features and screening. Endocrinology and Metabolism Clinics of North America. 23(1):1994;137-156.
16. Carlson K.M., Bracamontes J., Jackson C.E., Clark R., Lacroix A., Wells S.A., Goodfellow P.J. Parent-of-origin effects in multiple endocrine neoplasia type 2B. American Journal of Human Genetics. 55:1994;1076-1082.
17. Miller C.A., Ellison E.C. Multiple endocrine neoplasia type 2B. Clark O.H., Duh Q.Y. Textbook of Endocrine Surgery. 1997;619-625 W.B. Saunders Company, Philadelphia.
18. Takashi M., Ritz J., Cooper G.M. Activation of a novel human transforming gene, ret, by DNA arrangement. Cell. 42:1985;581-588.
19. Mathew C.G., Chin K.S., Easton D.F., Thorpe K., Carter C., Liou G.I., Fong S.L., Bridges C.D., Haak H., Nieuwenhuijzen-Kruseman A.C., Schifter S., Hansen H.H., Telenius H., Telenius-Berg M., Ponder B.A. A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature. 328:1987;527-530.
20. Gardner E., Papi L., Easton D., Cummings T., Jackson C.E., Kaplan M., Love D.R., Mole S.E., Moore J.K., Mulligan L.M., Norum R.A., Ponder M.A., Reichlin S., Stall G., Telenius H., Telenius-Berg M., Tunnacliffe A., Ponder B.A. Genetic linkage studies map the multiple endocrine neoplasia type 2 loci to a small interval on chromosome 10q11.2. Human Molecular Genetics. 2(3):1993;241-246.
21. Pasini B., Hofstra R.M., Yin L., Bocciardi R., Santamaria G., Grootscholten P., Ceccherini I., Patrone G., Priolo M., Buys C.H., Romeo G. The physical map of the human RET proto-oncogene. Oncogene. 11:1995;1737-1743.
22. Santoro M., Melillo R.M., Carlomagno F., Visconti R., DeVita G., Salvatore G., Lupoli G., Fusco A., Vecchio G. Molecular biology of the MEN2 gene. Journal of International Medicine. 243:1998;505-508.
23. Ponder B.A. The phenotypes associated with ret mutations in the multiple endocrine neoplasia type 2 syndrome. Cancer Research. 59(Suppl):1999;1736-1742.
24. Schuchardt A., D'Agati V., Larsson-Blomberg L., Costantini F., Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature. 367:1994;380-383.
25. Santoro M., Carlomagno F., Romano A., Bottaro D.P., Dathan N.A., Grieco M., Fusco A., Vecchio G., Matoskova B., Kraus M.H., Di Fiore P.P. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science. 267:1995;381-383.
26. Lairmore T.C., Howe J.R., Korte J.A., Dilley W.G., Aine L., Aine E., Wells S.A., Donis-Keller H. Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A. Genomics. 9:1991;181-192.
27. Carlson K.M., Dou S., Chi D., Scavarda N., Toshima K., Jackson C.E., Wells S.A., Goodfellow P.J., Donis-Keller H. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proceedings of the National Academy of Science USA. 91:1994;1579-1583.
28. Hofstra R.M., Landsvater R.M., Ceccherini I., Stulp R.P., Stelwagen T., Luo Y., Pasini B., Hoppener J.W., van Amstel H.K., Romeo G., Lips C.J., Buys C.H. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature. 367:1994;375-376.
29. Acton D.S., Velthuyzen D., Lips C.J., Hoppener J.W. Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice. Oncogene. 19:2000;3121-3125.
30. Eng C., Mulligan L.M., Smith D.P., Healey C.S., Frilling A., Raue F., Neumann H.P., Pfragner R., Behmel A., Lorenzo M.J., Stonehouse T.J., Ponder M.A., Ponder B.A. Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma. Genes, Chromosomes and Cancer. 12:1995;209-212.
31. Zedenius J., Larsson C., Bergholm U., Bovee J., Svensson A., Hallengren B., Grimelius L., Backdahl M., Weber G., Wallin G. Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas. Journal of Clinical Endocrinology and Metabolism. 80(10):1995;3088-3090.
32. Gimm O., Marsh D.J., Andrew S.D., Frilling A., Dahia P.L., Mulligan L.M., Zajac J.D., Robinson B.G., Eng C. Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. Journal of Clinical Endocrinology and Metabolism. 82(11):1997;3902-3904.
33. Smith D.P., Houghton C., Ponder B.A. Germline mutation of RET codon 883 in two cases of de novo MEN 2B. Oncogene. 15:1997;1213-1217.
34. Eng C., Clayton D., Schuffenecker I., Lenoir G., Cote G., Gagel R.F., van Amstel H.K., Lips C., Nishisho I., Takai S.I., Marsh D.J., Robinson B.G., Frank-Raue K., Raue F., Xue F., Noll W.W., Romei C., Pacini F., Fink M., Niederle B., Zedenius J., Nordenskjold M., Komminoth P., Hendey G., Gharib H., Thibodeau S.N., Lacroix A., Frilling A., Ponder B.A., Mulligan L.M. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2 - International RET Mutation Consortium Analysis. Journal of the American Medical Association. 276(19):1996;1575-1579.
35. Schimke R.N. Phenotype of malignancy. the mucosal neuroma syndrome Pediatrics. 52(2):1973;283-284.
36. Fink A., Lapidot M., Spierer A. Ocular manifestations in multiple endocrine neoplasia type 2b. American Journal of Ophth. 126(2):1998;305-307.
37. Saad M.F., Ordonez N.G., Rashid R.K., Guido R.K., Hill C.S., Hickey R.C., Samaan N.A. Medullary carcinoma of the thyroid - a study of the clinical features and prognostic factors in 161 patients. Medicine. 63(6):1984;319-342.
38. Carney J.A., Go V.L., Sizemore G.W., Hayles A.B. Alimentary-tract ganglioneuromatosis. New England Journal of Medicine. 295(23):1976;1287-1291.
39. Romeo G., Ceccherini I., Celli J., Priolo M., Betsos N., Bonardi G., Seri M., Yin L., Lerone M., Jasonni V., Martucciello G. Association of multiple endocrine neoplasia type 2 and Hirschprung disease. Journal of International Medicine. 243:1998;515-520.
40. Pasini B., Borrello M.G., Greco A., Bongarzone I., Luo Y., Mondellini P., Alberti L., Miranda C., Arighi E., Bocciardi R., Seri M., Barone V., Radice M.T., Romeo G., Pierotti M.A. Loss of function effect of RET mutations causing Hirschsprung disease. Nature Genetics. 10:1995;35-40.
41. Morrison P.J., Nevin N.C. Multiple endocrine neoplasia type 2B (mucosal neuroma syndrome, Wagenmann-Froboese syndrome). Journal of Medical Genetics. 33:1996;779-782.
42. Kebebew E., Ituarte P.H., Siperstein A.E., Duh Q.Y., Clark O.H. Medullary thyroid carcinoma - clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer. 88(5):2000;1139-1148.
43. Samaan N.A., Draznin M.B., Halpin R.E., Bloss R.S., Hawkins E., Lewis R.A. Multiple endocrine syndrome type IIb in early childhood. Cancer. 68:1991;1832-1834.
44. Heshmati H.M., Hofbauer L.C. Multiple endocrine neoplasia type 2. recent progress in diagnosis and management European Journal of Endocrinology. 137:1997;572-578.
45. Moley J.F. The molecular genetics of multiple endocrine neoplasia type 2A and related syndromes. Annual Review of Medicine. 48:1997;409-420.
46. Kambouris M., Jackson C.E., Feldman G.L. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B, and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations. Human Mutation. 8:1996;64-70.
47. Krausz Y., Rosler A., Guttmann H., Ish-shalom S., Shibley N., Chisin R., Glaser B. Somatostatin receptor scintigaphy for early detection of regional and distant metastases of medullary carcinoma of the thyroid. Clinical Nuclear Medicine. 24(4):1999;256-260.
48. Telander R.L., Zimmerman D., van Heerden J.A., Sizemore G.W. Results of early thyroidectomy for medullary thyroid carcinoma in children with multiple endocrine neoplasia type 2. Journal of Pediatric Surgery. 21(12):1986;1190-1194.
49. O'Riordain D.S., O'Brien T., Crotty T.B., Gharib H., Gran C.S., van Heerden J.A. Multiple endocrine neoplasia type 2B. more than an endocrine disorder Surgery. 118(6):1995;936-942.
50. Learoyd D.L., Marsh D.J., Richardson A.L., Twigg S.M., Delbridge L., Robinson B.G. Genetic testing for familial cancer - consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2. Archives of Surgery. 132:1997;1022-1025.
51. Wells S.A., Skinner M.A. Prophylactic thyroidectomy, based on direct genetic testing, in patients at risk for the multiple endocrine neoplasia type 2 syndromes. Experimental and Clinical Endocrinology Diabetes. 106:1998;29-34.
52. Evans D.B., Lee J.E., Merrell R.C., Hickey R.C. Adrenal medullary disease in multiple endocrine neoplasia type 2. Endocrinology and Metabolism and Clinics of North America. 23(1):1994;167-185.
53. Peplinski G.R., Norton J.A. The predictive value of diagnostic tests for pheochromocytoma. Surgery. 116:1994;1101-1110.
54. Eisenhofer G., Lenders J.W., Linehan W.M., Walter M.M., Goldstein D.S., Keiser H.R. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. New England Journal of Medicine. 340(24):1999;1872-1879.
55. De Graaf J.S., Dullaart R.P., Piers D.A., Zwierstra R.P. Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II. European Journal of Surgery. 166:2000;289-292.
56. Van Heerden J.A., Sizemore G.W., Carney J.A., Grant C.S., ReMine W.H., Sheps S.G. Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome. World Journal of Surgery. 8:1984;612-621.
57. Walther M.M., Herring J., Choyke P.L., Linehan W.M. Laparoscopic partial adrenalectomy in patients with hereditary forms of pheochromocytoma. Journal of Urology. 164:2000;14-17.
58. Inabnet W.B., Pitre J., Bernard D., Chapuis Y. Comparison of the hemodynamic parameters of open and laparoscopic adrenalectomy for pheochromocytoma. World Journal of Surgery. 24:2000;574-578.
59. Heniford T., Iannitti D.A., Hale J., Gagner M. The role of intraoperative ultrasonography during laparoscopic adrenalectomy. Surgery. 122:1997;1068-1074.